Hemophilia Services Consortium Inc

Analysis

Hemophilia Services Consortium Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in September 1997, 29 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Hemophilia Services Consortium Inc reported income of $21.2m and spending of $21.2m, spending 100% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $16.6m to $21.2m (+28%), an average of +6.4% a year. Over the whole period it spent 100% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Hemophilia Services Consortium Inc sits at the 89th percentile: it is larger than about 89% of them. Against every charity in United States with reported income it ranks in the 97th percentile, and in the 96th percentile within NY. Charities of a similar size with the same main cause include Wellstar Sylvan Grove Hospital Inc ($21.2m), Willamette Family Inc ($21.2m) and Self Regional Healthcare Partners ($21.2m).

On its Form 990 for the period ending June 2023, revenue came from program service revenue 99% of the total. At year end it held assets of $7.7m against liabilities of $7.6m, net assets of $124k.